JP2018511616A5 - - Google Patents

Download PDF

Info

Publication number
JP2018511616A5
JP2018511616A5 JP2017553122A JP2017553122A JP2018511616A5 JP 2018511616 A5 JP2018511616 A5 JP 2018511616A5 JP 2017553122 A JP2017553122 A JP 2017553122A JP 2017553122 A JP2017553122 A JP 2017553122A JP 2018511616 A5 JP2018511616 A5 JP 2018511616A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
compound according
unsubstituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017553122A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018511616A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/027549 external-priority patent/WO2016168472A1/en
Publication of JP2018511616A publication Critical patent/JP2018511616A/ja
Publication of JP2018511616A5 publication Critical patent/JP2018511616A5/ja
Pending legal-status Critical Current

Links

JP2017553122A 2015-04-14 2016-04-14 短鎖デヒドロゲナーゼ活性を調節する組成物および方法 Pending JP2018511616A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562147305P 2015-04-14 2015-04-14
US62/147,305 2015-04-14
PCT/US2016/027549 WO2016168472A1 (en) 2015-04-14 2016-04-14 Compositions and methods of modulating short-chain dehydrogenase activity

Publications (2)

Publication Number Publication Date
JP2018511616A JP2018511616A (ja) 2018-04-26
JP2018511616A5 true JP2018511616A5 (https=) 2019-05-30

Family

ID=57127188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017553122A Pending JP2018511616A (ja) 2015-04-14 2016-04-14 短鎖デヒドロゲナーゼ活性を調節する組成物および方法

Country Status (8)

Country Link
US (4) US20180118756A1 (https=)
EP (1) EP3283074A4 (https=)
JP (1) JP2018511616A (https=)
CN (1) CN108012528A (https=)
AU (1) AU2016248080A1 (https=)
CA (1) CA2982784A1 (https=)
HK (1) HK1250651A1 (https=)
WO (1) WO2016168472A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
US11718589B2 (en) 2017-02-06 2023-08-08 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase
US12336982B2 (en) 2018-11-21 2025-06-24 Rodeo Therapeutics Corporation Compositions and methods of modulating short-chain dehydrogenase activity
US12616681B2 (en) 2022-08-22 2026-05-05 Case Western Reserve University Compositions and methods for treating renal injury

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801863B2 (en) 2012-04-16 2017-10-31 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
DK2838533T3 (da) 2012-04-16 2017-11-27 Univ Case Western Reserve Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet
AU2014342811B2 (en) 2013-10-15 2019-01-03 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
CN107921025A (zh) 2015-03-08 2018-04-17 卡斯西部储备大学 用于治疗纤维症的短链脱氢酶活性的抑制剂
US20190275014A1 (en) * 2016-07-18 2019-09-12 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for promoting neurogenesis and inhibiting cell death
WO2018187810A1 (en) * 2017-04-07 2018-10-11 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
JP7426941B2 (ja) * 2018-04-04 2024-02-02 ケース ウエスタン リザーブ ユニバーシティ 腎傷害を治療するための組成物および方法
TWI834795B (zh) 2019-01-08 2024-03-11 日商杏林製藥股份有限公司 15-pgdh抑制劑
EP3917911A1 (en) 2019-01-31 2021-12-08 Kyorin Pharmaceutical Co., Ltd. 15-pgdh inhibitors
EP3982957A4 (en) * 2019-06-11 2023-06-21 The Board of Trustees of the Leland Stanford Junior University METHODS OF REJUVENATING AGED TISSUE BY INHIBITION OF 15-HYDROXYPROSTAGLANDINE DEHYDROGENASE (15-PGDH)
JP2023515081A (ja) * 2020-02-21 2023-04-12 ケース ウエスタン リザーブ ユニバーシティ 腎損傷を治療するための組成物および方法
AU2021275122A1 (en) 2020-05-20 2022-12-15 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
CN117377668A (zh) * 2020-10-15 2024-01-09 迈欧伏特治疗公司 Pgdh抑制剂的吸入制剂及其使用方法
US20240000758A1 (en) * 2020-10-23 2024-01-04 The Board Of Trustees Of The Leland Stanford Junior University Elevation of mitochondrial biogenesis and function by inhibition of prostaglandin degrading enzyme 15-pgdh
CA3200394A1 (en) * 2020-12-09 2022-06-16 Helen M. Blau Inhibition of prostaglandin degrading enzyme 15-pgdh to improve joint structure and function
CA3243368A1 (en) * 2022-01-28 2025-01-16 Scinnohub Pharmaceutical Co., Ltd. COMPOUND FOR REGULATING AND CONTROLLING THE ACTIVITY OF 15-PGDH AND ITS PREPARATION PROCESS
US20250250283A1 (en) * 2022-04-13 2025-08-07 Scinnohub Pharmaceutical Co., Ltd. Compound capable of regulating and controlling activity of 15-pgdh, and preparation method therefor
TW202419452A (zh) * 2022-11-11 2024-05-16 大陸商賽諾哈勃藥業(成都)有限公司 調控15-pgdh活性的化合物、其藥物組合物及其用途
CN118027057A (zh) * 2022-11-14 2024-05-14 武汉人福创新药物研发中心有限公司 抑制15-pgdh的化合物及其用途
CN121443609A (zh) * 2023-05-19 2026-01-30 赛诺哈勃药业(成都)有限公司 一种调控15-pgdh活性的化合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904672A (en) * 1987-01-30 1990-02-27 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
EP1491541B1 (en) * 2001-03-30 2007-01-24 Pfizer Products Inc. Pyridazinone aldose reductase inhibitors
EP1558252B1 (en) * 2002-08-02 2007-10-10 Merck & Co., Inc. Substituted furo [2,3-b]pyridine derivatives
WO2006019832A1 (en) * 2004-07-22 2006-02-23 Ptc Therapeutics, Inc. Thienopyridines for treating hepatitis c
TW200801012A (en) * 2006-04-26 2008-01-01 Piramed Ltd Phosphoinositide 3-kinase inhibitor compounds and methods of use
US20100093764A1 (en) * 2008-10-13 2010-04-15 Devraj Chakravarty AMINES AND SULFOXIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
KR101172638B1 (ko) * 2008-12-30 2012-08-08 조선대학교산학협력단 신규한 티아졸리딘디온 유도체 및 그의 용도
DK2838533T3 (da) * 2012-04-16 2017-11-27 Univ Case Western Reserve Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet
US9801863B2 (en) * 2012-04-16 2017-10-31 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
AU2014342811B2 (en) * 2013-10-15 2019-01-03 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
CN107921025A (zh) * 2015-03-08 2018-04-17 卡斯西部储备大学 用于治疗纤维症的短链脱氢酶活性的抑制剂
JP2019078488A (ja) * 2017-10-25 2019-05-23 ダイキン工業株式会社 空気調和装置

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
US11718589B2 (en) 2017-02-06 2023-08-08 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase
US12336982B2 (en) 2018-11-21 2025-06-24 Rodeo Therapeutics Corporation Compositions and methods of modulating short-chain dehydrogenase activity
US12616681B2 (en) 2022-08-22 2026-05-05 Case Western Reserve University Compositions and methods for treating renal injury

Similar Documents

Publication Publication Date Title
JP2018511616A5 (https=)
JP2020514323A5 (https=)
JP2006502247A5 (https=)
JP2008533191A5 (https=)
JP2010515731A5 (https=)
WO2006098918B1 (en) Substituted gamma lactams as therapeutic agents
JP2007534702A5 (https=)
JP2009535307A5 (https=)
WO2008042240A3 (en) Enantiomerically pure phosphoindoles as hiv inhibitors
NZ593030A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
WO2009013299A3 (de) Neue bradykinin b1-antagonisten
RU2010139644A (ru) Ингибитор фиброза
EP2292590A3 (en) Prodrugs of 9-aminomethyl tetracycline compounds
EP2207062A3 (en) Photosensitive compositions, curable compositions, novel compounds, photopolymerizable compositions, color filters, and planographic printing plate precursors
JP2018530582A5 (https=)
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
RU2009139920A (ru) Изоксазолиновые соединения и их применение в борьбе с вредителями
JP2008509166A5 (https=)
RU2010121763A (ru) Производные пиридазинона и ингибиторы р2х7 рецептора
FI2291080T5 (fi) Uusia sfingosiinifosfaattireseptorimodulaattoreita
JP2010077141A5 (https=)
SI2718293T1 (en) SUBSTITUTED PYRIDOPIRAZINS AS NEW INHIBITORS OF VRANIC TYROSIN KINASE (SYK)
JP2010504286A5 (https=)
HRP20140501T1 (hr) Derivati benzazepina korisni kao antagonisti vazopresina
ME02472B (me) Nitrogenovano heterociklično jedinjenje i poljoprivredni ili hortikulturni fungicid